No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families

scientific article published on 01 January 2006

No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/GTE.2006.10.104
P698PubMed publication ID16792513

P50authorDavid GoldgarQ91793745
P2093author name stringJean Lépine
Jacques Simard
Rachel Laframboise
Marie Plante
Martine Dumont
Bernard Lespérance
Jocelyne Chiquette
Anne-Marie Moisan
Jessyka Fortin
Louise Provencher
Patricia Voyer
Paul Bessette
Peter Bridge
Roxane Pichette
Carolle Samson
P433issue2
P304page(s)104-115
P577publication date2006-01-01
P1433published inGenetic Testing and Molecular BiomarkersQ15753742
P1476titleNo Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families
P478volume10

Reverse relations

cites work (P2860)
Q24632225A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer
Q36884722A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families.
Q81978444Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women
Q37011975BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Q37778781Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.
Q37004792Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
Q46944912Genetic sequence variations and ADPRT haplotype analysis in French Canadian families with high risk of breast cancer
Q54646155Genomic Large Rearrangement Screening ofBRCA1andBRCA2Genes in High-Risk Turkish Breast/Ovarian Cancer Patients by Using Multiplex Ligation-Dependent Probe Amplification Assay
Q34562526Genomic rearrangements in BRCA1 and BRCA2: A literature review.
Q64899091Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation.
Q57222828Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea
Q33258847Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
Q39991531Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families
Q26741855New challenges for BRCA testing: a view from the diagnostic laboratory
Q42377409Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients
Q57212483mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea

Search more.